Kilitch Drugs (India) (BOM:524500) 5-Year EBITDA Growth Rate : 31.30% (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) 5-Year EBITDA Growth Rate?

Kilitch Drugs (India)'s EBITDA per Share for the three months ended in Dec. 2024 was ₹6.51.

During the past 12 months, Kilitch Drugs (India)'s average EBITDA Per Share Growth Rate was 16.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 52.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 31.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kilitch Drugs (India) was 103.60% per year. The lowest was -51.40% per year. And the median was 4.40% per year.

Competitive Comparison of Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Kilitch Drugs (India) 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kilitch Drugs (India) (BOM:524500) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Kilitch Drugs (India) 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kilitch Drugs (India) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

KILITCH:India

Address

Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088

Website

https://www.kilitch.com

Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines